Abstract
We present ReDU (https://redu.ucsd.edu/), a system for metadata capture of public mass spectrometry-based metabolomics data, with validated controlled vocabularies. Systematic capture of knowledge enables the reanalysis of public data and/or co-analysis of one’s own data. ReDU enables multiple types of analyses, including finding chemicals and associated metadata, comparing the shared and different chemicals between groups of samples, and metadata-filtered, repository-scale molecular networking.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Progress and challenges in exploring aquatic microbial communities using non-targeted metabolomics
The ISME Journal Open Access 19 October 2023
-
Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry
Nature Communications Open Access 31 August 2023
-
Eco-Metabolomics Applied to the Chemical Ecology of Poison Frogs (Dendrobatoidea)
Journal of Chemical Ecology Open Access 18 August 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout


Data availability
Source data for the results presented in this paper are available on GitHub (https://github.com/mwang87/ReDU-MS2-GNPS/tree/master/examples). All curated sample information can be downloaded from the ReDU homepage (https://redu.ucsd.edu/) by selecting ‘Download Database’. The current version of the ReDU information used to generate the results in this paper is archived in the GNPS/MassIVE repository (http://gnps.ucsd.edu). The accession number is MSV000084206 (https://doi.org/10.25345/C5407D).
Code availability
All software is citable using https://doi.org/10.5281/zenodo.3924422. Up-to-date developments of ReDU are available in GitHub (https://github.com/mwang87/ReDU-MS2-GNPS), with corresponding documentation (https://github.com/mwang87/ReDU-MS2-Documentation).
References
Wang, M. et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 34, 828–837 (2016).
Haug, K. et al. MetaboLights: a resource evolving in response to the needs of its scientific community. Nucleic Acids Res. 48, D440–D444 (2020).
Sud, M. et al. Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463–D470 (2016).
Federhen, S. The NCBI Taxonomy database. Nucleic Acids Res. 40, D136–D143 (2012).
Mungall, C. J., Torniai, C., Gkoutos, G. V., Lewis, S. E. & Haendel, M. A. Uberon, an integrative multi-species anatomy ontology. Genome Biol. 13, R5 (2012).
Schriml, L. M. & Mitraka, E. The Disease Ontology: fostering interoperability between biological and clinical human disease-related data. Mamm. Genome 26, 584–589 (2015).
Scheubert, K. et al. Significance estimation for large scale metabolomics annotations by spectral matching. Nat. Commun. 8, 1494 (2017).
Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis: Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211–221 (2007).
Vázquez-Baeza, Y., Pirrung, M., Gonzalez, A. & Knight, R. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience 2, 1–4 (2013).
Hammons, J. L., Jordan, W. E., Stewart, R. L., Taulbee, J. D. & Berg, R. W. Age and diet effects on fecal bile acids in infants. J. Pediatr. Gastroenterol. Nutr. 7, 30–38 (1988).
Robertson, R. C., Manges, A. R., Finlay, B. B. & Prendergast, A. J. The human microbiome and child growth—first 1000 days and beyond. Trends Microbiol. 27, 131–147 (2019).
Martin, C. B., Hales, C. M., Gu, Q. & Ogden, C. L. Prescription drug use in the United States, 2015–2016 (NCHS Data Brief no. 334) https://www.cdc.gov/nchs/products/databriefs/db334.htm (2019).
Omura, S. et al. A new alkaloid Am-2282 of Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J. Antibiot. 30, 275–282 (1977).
Peypoux, F., Bonmatin, J. M. & Wallach, J. Recent trends in the biochemistry of surfactin. Appl. Microbiol. Biotechnol. 51, 553–563 (1999).
Ernst, M. et al. Molnetenhancer: enhanced molecular networks by integrating metabolome mining and annotation tools. Metabolites 9, 144 (2019).
Wynalda, M. A., Hutzler, J. M., Koets, M. D., Podoll, T. & Wienkers, L. C. In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metab. Dispos. 31, 878–887 (2003).
Protsyuk, I. et al. 3D molecular cartography using LC–MS facilitated by Optimus and ’ili software. Nat. Protoc. 13, 134–154 (2018).
Wilkinson, M. D. et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci. Data 3, 160018 (2016).
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
Acknowledgements
We thank the individuals involved in the funding, administration, sample collection and data acquisition of the public data used in ReDU. We recognize the financial support of the US National Institutes of Health (P41 GM103484, R03 CA211211, R01 LM013115 and R01 GM107550), the Sloan Foundation (R.K.), the Gordon and Betty Moore Foundation (P.C.D., N.B., K.L.M.), a FAPESP fellowship (2018/24865-4), the American Society for Mass Spectrometry (A.K.J.), NSF grants IOS-1656481 (P.C.D. and A.M.C.R.) and ABI-1759980, Netherlands eScience Center no. ASDI.2017.030 (J.J.J.v.d.H.), the Krupp Endowed Fund (R. Coras), the US Office of Naval Research (N00014-15-1-2809) and the University of California, San Diego, Center for Microbiome Innovation SEED grants.
Author information
Authors and Affiliations
Contributions
A.K.J., M.W. and P.C.D. developed the ReDU concept. A.K.J., M.W. and C.M.A. wrote code and engineered the ReDU infrastructure. A.K.J., C.M.A., R.S.A., S.A., A.A.A., G.A., A.T.A., A. Bauermeister, S.B., A. Bouslimani, A.M.C.R., R. Chaar, R. Coras, E.O.E., J.J.J.v.d.H., J.M.G., E.C.G., M.H., K.L.J., Z.K., A.L.G., A.L., L.-I.M., K.L.M., M.J.M., A.V.M., R.C.M., Y.A.M.G., N.H.N., L.F.N., M.E., M.N.E., M.P., D.P., R.Q., N.S., F.V., A.V. and K.C.W. curated metadata enabling ReDU. A.K.J., M.W., C.M.A., S.A.J., L.-I.M., M.E., J.J.J.v.d.H., J.M.G., M.P. and P.C.D. tested the ReDU infrastructure and provided feedback. A.K.J., M.W., C.M.A., M.E., J.J.J.v.d.H., R.K., N.B. and P.C.D. wrote and edited the manuscript. R.K., N.B. and P.C.D. provided supervision and funding support.
Corresponding author
Ethics declarations
Competing interests
P.C.D. is a scientific advisor for Sirenas LLC, Galileio and Cybele Microbiome and scientific advisor and co-founder of Enveda. M.W. is a founder of Ometa Labs LLC. A.A. is a consultant for Ometa Labs LLC.
Additional information
Peer review information Allison Doerr was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Repository-scale molecular cartography enabled by ReDU.
ReDU samples with latitude and longitude information, n = 34,003, were grouped by latitude and longitude (n = 2068 different locations) and plotted colored by number of annotations per file (log10 scaled).
Extended Data Fig. 2 Comparison of bacterial cultures using Group Comparator in ReDU.
Bacterial cultures of 1280|Staphylococcus aureus (n = 49), 1423|Bacillus subtilis (n = 89), and 1883|Streptomyces (n = 7) were compared and chemical differences are illustrated by pyroGlu-Ile, staurosporine, and surfactin-C14.
Extended Data Fig 3 Repository-scale molecular networking of human blood (n = 711), fecal (n = 5,097), and urine (n = 307) supplemented by MolNetEnhancer.
(a) MolNetEnhancer enhanced molecular network in which components are colored based on Classyfire chemical class prediction. (b) Number of nodes per Classyfire chemical class prediction. Nodes without a match in Classyfire are not displayed.
Extended Data Fig 4 Molecular cartography of the distribution of drugs on the human body visualized using ili.
Descaladinose azithromycin, a drug metabolite of azithromycin, distribution in human (n = 17,117; normalized by the number of files per sample).
Supplementary information
Supplementary Information
Supplementary Discussion, Supplementary Table 1 and Supplementary Figs. 1–5.
Supplementary Table 2
Tabulated information for proposed clindamycin metabolites based on repository-scale molecular networking in ReDU.
Supplementary Video 1
The empirically observed UBERON-based location of drugs and drug metabolites observed in metabolomics data 28 August 2019–10 July 2020 processed through ReDU.
Rights and permissions
About this article
Cite this article
Jarmusch, A.K., Wang, M., Aceves, C.M. et al. ReDU: a framework to find and reanalyze public mass spectrometry data. Nat Methods 17, 901–904 (2020). https://doi.org/10.1038/s41592-020-0916-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41592-020-0916-7
This article is cited by
-
Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry
Nature Communications (2023)
-
Progress and challenges in exploring aquatic microbial communities using non-targeted metabolomics
The ISME Journal (2023)
-
How is Big Data reshaping preclinical aging research?
Lab Animal (2023)
-
Eco-Metabolomics Applied to the Chemical Ecology of Poison Frogs (Dendrobatoidea)
Journal of Chemical Ecology (2023)
-
Artificial intelligence for natural product drug discovery
Nature Reviews Drug Discovery (2023)